NeuPath Health Inc.
NPTH.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.31% | 8.09% | 9.22% | 4.31% | 2.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.31% | 8.09% | 9.22% | 4.31% | 2.74% |
| Cost of Revenue | 7.27% | 6.47% | 8.61% | 2.12% | 0.43% |
| Gross Profit | 7.50% | 15.09% | 12.00% | 14.58% | 14.53% |
| SG&A Expenses | 6.27% | 9.21% | 8.79% | 9.94% | -2.52% |
| Depreciation & Amortization | -9.82% | -11.01% | -7.19% | 10.06% | -4.55% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.46% | 6.20% | 8.02% | 3.54% | -0.21% |
| Operating Income | 2,277.78% | 92.20% | 491.22% | 118.82% | 101.32% |
| Income Before Tax | -154.27% | 259.13% | -67.37% | 79.24% | 143.82% |
| Income Tax Expenses | -62.13% | -8.88% | 7.91% | -144.86% | 167.55% |
| Earnings from Continuing Operations | -189.22% | 673.68% | -53.37% | 80.26% | 130.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -464.33% | -308.66% | -203.28% | -102.27% | -64.72% |
| Net Income | -204.59% | 277.49% | -97.46% | 79.75% | 133.93% |
| EBIT | 2,277.78% | 92.20% | 491.22% | 118.82% | 101.32% |
| EBITDA | 12.02% | 28.42% | 22.70% | 84.19% | 215.65% |
| EPS Basic | -204.00% | 280.00% | -85.19% | 81.95% | 130.30% |
| Normalized Basic EPS | -12.50% | 100.00% | 37.50% | 9.09% | 69.23% |
| EPS Diluted | -246.00% | 280.00% | -174.07% | 81.95% | 130.30% |
| Normalized Diluted EPS | -12.50% | 100.00% | 37.50% | 9.09% | 66.67% |
| Average Basic Shares Outstanding | 0.22% | 1.17% | 7.82% | 11.88% | 12.17% |
| Average Diluted Shares Outstanding | 0.19% | 1.30% | 8.00% | 11.88% | 3.56% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
